Get started
Author

Qiji Li

N-cadherin promotes epithelial-mesenchymal transition and cancer stem cell-like traits via ErbB signaling in prostate cancer cells
2015 · MIN WANG, DONG REN, et al. · International Journal of Oncology · 136
PDF
MYBL2 disrupts the Hippo-YAP pathway and confers castration resistance and metastatic potential in prostate cancer
2021 · Qiji Li, Min Wang, et al. · Theranostics · 116
Epigenetic silencing of SALL2 confers tamoxifen resistance in breast cancer
2019 · Liping Ye, Chuyong Lin, et al. · EMBO Molecular Medicine · 83
FZD8, a target of p53, promotes bone metastasis in prostate cancer by activating canonical Wnt/β-catenin signaling
2017 · Qiji Li, Liping Ye, et al. · Cancer Letters · 71
Acidic extracellular pH promotes prostate cancer bone metastasis by enhancing PC-3 stem cell characteristics, cell invasiveness and VEGF-induced vasculogenesis of BM-EPCs
2016 · Sheng Huang, Yubo Tang, et al. · Oncology Reports · 56
PDF
Transcriptional downregulation of miR-133b by REST promotes prostate cancer metastasis to bone via activating TGF-β signaling
2018 · Shuai Huang, Qingde Wa, et al. · Cell Death and Disease · 37
PDF
Overexpression of TACC3 is correlated with tumor aggressiveness and poor prognosis in prostate cancer
2017 · Qiji Li, Liping Ye, et al. · Biochemical and Biophysical Research Communications · 37
PHF21B overexpression promotes cancer stem cell-like traits in prostate cancer cells by activating the Wnt/β-catenin signaling pathway
2017 · Qiji Li, Liping Ye, et al. · Journal of Experimental & Clinical Cancer Research · 34
PDF
Disruption of the mouse Bmal1 locus promotes heterotopic ossification with aging via TGF-beta/BMP signaling
2021 · Qian Liang, Yingsi Lu, et al. · Journal of Bone and Mineral Metabolism · 17
Deletion of Wild-type p53 Facilitates Bone Metastatic Function by Blocking the AIP4 Mediated Ligand-Induced Degradation of CXCR4
2022 · Qiji Li, Min Wang, et al. · Frontiers in Pharmacology · 13
Erratum To: Epigenetic silencing of SALL2 confers tamoxifen resistance in breast cancer
2022 · Liping Ye, Chuyong Lin, et al. · EMBO Molecular Medicine · 9
RNA-binding protein LSM7 facilitates breast cancer metastasis through mediating alternative splicing of CD44
2024 · Chenxin Li, Yuhao Zhang, et al. · Life Sciences · 6
Branched‐Chain α Keto‐Acid Dehydrogenase Kinase‐Mediated AKT Phosphorylation Promotes RCC Tumorigenesis and Drug Resistance
2025 · Qin Tian, Jinxiang Wang, et al. · Advanced Science · 3
PDF
Integrated network pharmacology, molecular docking and metabolomics studies to reveal the therapeutic effects of Armillaria gallica extract for treating depression in CUMS-induced mice
2026 · Xiu Yang, Xiu Yang, et al. · Journal of Ethnopharmacology · 2
The tumor suppressor SALL2 opposes chemotherapeutic resistance in breast cancer
2024 · Qiji Li, Chenxin Li, et al. · Molecular and Cellular Biochemistry · 2
DYNLT1–TP53BP2 axis drives tamoxifen resistance in breast cancer by activating PI3K/Akt/mTOR signaling
2026 · Qiji Li, Zihan Zheng, et al. · Life Sciences
LCAL4–FUS cooperation switches on MMP13 and drives osteolytic bone metastasis in breast cancer
2026 · Qiji Li, Mingjian Fan, et al. · Oncogene
PDF
Fermented Gastrodia elata Blume ameliorates CUMS-induced depression in mice: synergistic regulation of cAMP/BDNF/CREB signaling and gut microbiota-metabolite axis
2025 · Ming Gao, Xiu Yang, et al. · Journal of Future Foods
N6-methyladenosine modification of DYNLT1 Facilitates Tamoxifen Resistance in Luminal B Breast Cancer
2024 · Qiji Li, Chenxin Li, et al. · Research Square
Corrigendum to “FZD8, a target of p53, promotes bone metastasis in prostate cancer by activating canonical Wnt/β-catenin signaling” [Cancer Lett. 402 (2017) 166–176]
2021 · Qiji Li, Liping Ye, et al. · Cancer Letters
Impact of Metabolic Syndrome on Prostate Cancer Diagnosis and Grade in Chinese Patients Undergoing Prostate Biopsy
2019 · Qian Zhang, Xingbin Wu, et al. · Journal of Oncology Research and Therapy
Works count: 21
Citation count: 622
H-index: 10
I10-index: 10
Year
Topic
Type